Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

Roche Basel Switzerland

Roche moves closer to US filing for alectinib

Results showed alectinib able to shrink tumours in half of cases

- PMLiVE

AZ links with Abbott on personalised asthma diagnostic

Diagnostic would aim to identify patients most likely to respond to tralokinumab

- PMLiVE

AZ to screen 80,000 patients for genetic disease traits

Will work with Montreal Heart to investigate cardiovascular and diabetic signals

Infographics: Disrupt or be disrupted

How to meet the new communication expectations.

Anthill Agency

- PMLiVE

Havas Lynx Group bolsters senior ranks

Agency sees three new appointments at the top of its organisation

- PMLiVE

Baxter buoys cancer presence with $900m Oncaspar deal

Leukaemia drug will be added to upcoming biopharma firm Baxalta

- PMLiVE

Michael Zaiac moves from GSK to Celgene

He takes up the role of VP, medical affairs, haematology-oncology EMEA

- PMLiVE

Juno boosts CAR-T presence with $80m German acquisition

Stage Cell Therapeutics will contribute in process development and manufacturing

- PMLiVE

Merck KGaA, Threshold gain FDA fast-track review

Industry partners hope their new cancer drug will be approved by the end of the year

- PMLiVE

George Freeman re-appointed as UK life science minister

Industry welcomes his continuation in this pharma-focused role

Pharma deals in March 2015

AbbVie's Pharmacyclics mega-merger dominated the month, finds Medius Deal Watch

Medius Deal Watch table for March 2015

The top major pharma mergers, acquisitions and collaborations during the month were dominated by AbbVie's Pharmacyclics mega-merger

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links